Small-molecule fluorescence-based probes for aging diagnosis

This new review article summarizes recent research progress in small-molecule fluorescence-based probes for aging diagnosis, and further discusses the challenges and opportunities in this field. Aging is a time-dependent decline in physiological function that affects most organisms and is the major risk factor for many non-communicable diseases. The early diagnosis of aging is critical for the treatment of aging and aging-related diseases. In recent years, extensive efforts have attempted to accurately diagnose aging. To date, multiple types of fluorescent probes for various age-related biomarkers have been developed, with the aims of achieving rapid, precise diagnosis of the aging process and evaluating the efficacy of anti-aging drugs.

Keywords: fluorescent probes, aging, senescence, diagnosis for aging, age-related biomarkers

Article Reference: Donglei Shi, Wenwen Liu and Guangwei Wang et al. Small-molecule fluorescence-based probes for aging diagnosis. Acta Materia Medica. Vol. 1(1). DOI: 10.15212/AMM-2021-0004

Acta Materia Medica provides an open platform for rapid publication of the latest findings, approaches, and viewpoints related to all related areas of pharmacy and pharmaceutical sciences, including, but not limited to, pharmacology, toxicology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics and pharmacy management.

Coverage includes:

  • Pathophysiology of important diseases and disease vectors
  • Novel therapeutic strategies
  • Novel methodologies facilitating the search for therapies
  • High-throughput screening, combinatorial chemistry, parallel synthesis and library design
  • 3D Structures and functions of therapeutic targets
  • Structural biological studies of relevant ligands and targets
  • Discovery, design and synthesis of biologically active agents, including natural products, therapeutic macromolecules
  • Drug delivery
  • ADME/Toxicology
  • Advances in key compound classes and therapeutic areas
  • Omics in pharmaceutical sciences
  • Biological databases, web-based software for pharmaceutical sciences
  • Studies of biological activity or mode of action.
  • Structure-activity correlations of drugs
  • Development of new imaging and diagnostic tools
  • Computational studies the SAR of compounds, target informatics
  • Business strategy for pharmaceutical industry
  • Clinical research and trials, meta-analysis
  • Management, commercial and regulatory issues in pharmaceutical R&D.
  • Other aspects of pharmacy and pharmaceutical sciences.

Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.

Submission Process

Submissions to Acta Materia Medica are made using ScholarOne, the online submission and peer review system. Registration and access are available at

Queries about the journal can be sent to